Medesis Pharma (STU:76D) ROE % Adjusted to Book Value : 0.00% (As of Jun. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Medesis Pharma ROE % Adjusted to Book Value?

Medesis Pharma's ROE % for the quarter that ended in Jun. 2024 was 0.00%. Medesis Pharma's PB Ratio for the quarter that ended in Jun. 2024 was N/A. Medesis Pharma's ROE % Adjusted to Book Value for the quarter that ended in Jun. 2024 was N/A.

Medesis Pharma ROE % Adjusted to Book Value Historical Data

The historical data trend for Medesis Pharma's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medesis Pharma ROE % Adjusted to Book Value Chart

Medesis Pharma Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROE % Adjusted to Book Value

Get a 7-Day Free Trial

Medesis Pharma Semi-Annual Data
	Dec18	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
ROE % Adjusted to Book Value	Get a 7-Day Free Trial						-2.87	-	-	-	-

Competitive Comparison of Medesis Pharma's ROE % Adjusted to Book Value

For the Biotechnology subindustry, Medesis Pharma's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Medesis Pharma's ROE % Adjusted to Book Value Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Medesis Pharma's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Medesis Pharma's ROE % Adjusted to Book Value falls into.

Save Embed

;

Save Embed

;

Medesis Pharma ROE % Adjusted to Book Value Calculation

Medesis Pharma's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	0.00%	/	N/A
	=	N/A

Medesis Pharma's ROE % Adjusted to Book Value for the quarter that ended in Jun. 2024 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	0.00%	/	N/A
	=	N/A

Medesis Pharma ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Medesis Pharma's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Medesis Pharma Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Medesis Pharma SA (STU:76D) » Definitions » ROE % Adjusted to Book Value

Comparable Companies

Traded in Other Exchanges

ALMDP:France 76D:Germany

Address

Loree des Mas, Avenue du golf, Baillargues, Montpellier, FRA, 34670

Website

https://www.medesispharma.com

Medesis Pharma SA is a clinical development stage biopharmaceutical company. It is engaged in the development of orally administered molecule drug candidates to expand therapeutic usefulness to address major unmet medical needs.

Medesis Pharma Headlines

No Headlines